{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:51:42Z","timestamp":1783047102329,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.thromres.2024.01.016","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T07:12:40Z","timestamp":1706166760000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study"],"prefix":"10.1016","volume":"235","author":[{"given":"Joonsang","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoul","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-9736","authenticated-orcid":false,"given":"Jinkwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2024.01.016_bb0005","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/annonc\/mdq777","article-title":"Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer","volume":"22","author":"Chavez-MacGregor","year":"2011","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.016_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: a review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"issue":"151","key":"10.1016\/j.thromres.2024.01.016_bb0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2018","article-title":"Cancer-associated thrombosis: the when, how and why","volume":"28","author":"Fernandes","year":"2019","journal-title":"Eur. Respir. Rev."},{"issue":"8","key":"10.1016\/j.thromres.2024.01.016_bb0025","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.thromres.2024.01.016_bb0030","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.21.01736","article-title":"Risk of cardiovascular disease in women with and without breast cancer: the pathways heart study","volume":"40","author":"Greenlee","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study","volume":"168","author":"Hultcrantz","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2024.01.016_bb0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/STROKEAHA.118.023044","article-title":"Short-term outcome of ischemic stroke patients with systemic malignancy","volume":"50","author":"Yoo","year":"2019","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.thromres.2024.01.016_bb0050","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3324\/haematol.2018.192419","article-title":"Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer","volume":"103","author":"Grilz","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.thromres.2024.01.016_bb0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as antithrombotic drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","article-title":"Statins and blood coagulation","volume":"25","author":"Undas","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"22","key":"10.1016\/j.thromres.2024.01.016_bb0070","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients","volume":"52","author":"Mills","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0075","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.thromres.2024.01.016_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105413","article-title":"Effect of statins on the risk of recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"165","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.thromres.2024.01.016_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106931","article-title":"Effects of statins in primary and secondary prevention for venous thromboembolism events: a meta analysis","volume":"142","author":"Zhu","year":"2022","journal-title":"Vasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.thromres.2024.01.016_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3349\/ymj.2022.63.4.333","article-title":"Impact of statin treatment intensity after endovascular revascularization on lower extremity peripheral artery disease","volume":"63","author":"Kim","year":"2022","journal-title":"Yonsei Med. J."},{"issue":"24","key":"10.1016\/j.thromres.2024.01.016_bb0095","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.thromres.2024.01.016_bb0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5853\/jos.2021.01249","article-title":"Role of blood lipid levels and lipid-lowering therapy in stroke patients with different levels of cerebral artery diseases: reconsidering recent stroke guidelines","volume":"23","author":"Kim","year":"2021","journal-title":"J Stroke"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020151","article-title":"Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer","volume":"15","author":"Morofuji","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research","volume":"11","author":"Kyoung","year":"2022","journal-title":"J Lipid Atheroscler"},{"issue":"10","key":"10.1016\/j.thromres.2024.01.016_bb0120","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/STROKEAHA.117.018140","article-title":"Effects of statin intensity and adherence on the long-term prognosis after acute ischemic stroke","volume":"48","author":"Kim","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005025","article-title":"A coronary heart disease prediction model: the Korean Heart Study","volume":"4","author":"Jee","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191897","article-title":"Incidence of venous thromboembolism in Korea from 2009 to 2013","volume":"13","author":"Hong","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.thromres.2024.01.016_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/oem.2004.014472","article-title":"An incidence density sampling program for nested case-control analyses","volume":"61","author":"Richardson","year":"2004","journal-title":"Occup. Environ. Med."},{"issue":"25","key":"10.1016\/j.thromres.2024.01.016_bb0140","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2024.01.016_bb0145","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3349\/ymj.2022.0273","article-title":"Impact of cardiovascular diseases on mortality in gastric cancer patients with preexisting chronic disease","volume":"63","author":"Han","year":"2022","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0150","first-page":"113","article-title":"Does cardiovascular mortality overtake cancer mortality during cancer survivorship?: an English retrospective cohort study","volume":"4","author":"Strongman","year":"2022","journal-title":"JACC: CardioOncology"},{"key":"10.1016\/j.thromres.2024.01.016_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.669288","article-title":"Epidemiology of cancer-associated thrombosis in Asia: a systematic review","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.thromres.2024.01.016_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015656","article-title":"Long-term association of venous thromboembolism with frailty, physical functioning, and quality of life: the atherosclerosis risk in communities study","volume":"9","author":"Lutsey","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.016_bb0165","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","article-title":"Physical activity in cancer prevention and survival: a systematic review","volume":"51","author":"McTiernan","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0170","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.thromres.2014.09.001","article-title":"Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study","volume":"134","author":"L\u00f6tsch","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.01.016_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2017.08.001","article-title":"Statin use and venous thromboembolism in cancer: a large, active comparator, propensity score matched cohort study","volume":"158","author":"El-Refai","year":"2017","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5853\/jos.2017.01802","article-title":"Incidental statin use and the risk of stroke or transient ischemic attack after radiotherapy for head and neck cancer","volume":"20","author":"Addison","year":"2018","journal-title":"J Stroke"},{"issue":"13","key":"10.1016\/j.thromres.2024.01.016_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005996","article-title":"Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck","volume":"8","author":"Boulet","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0190","doi-asserted-by":"crossref","first-page":"e018393","DOI":"10.1161\/JAHA.119.018393","article-title":"Statin exposure and risk of heart failure after anthracycline- or trastuzumab-based chemotherapy for early breast cancer: a propensity score\u2013matched cohort study","volume":"10","author":"H. Abdel-Qadir","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0195","first-page":"153","article-title":"Cardioprotective effect of statins in patients with HER2-positive breast cancer receiving trastuzumab therapy","volume":"35","author":"Calvillo-Arg\u00fcelles","year":"2019","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ehjci\/jeab034","article-title":"Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study","volume":"23","author":"Ota","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"21","key":"10.1016\/j.thromres.2024.01.016_bb0205","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2024.01.016_bb0215","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.thromres.2021.12.018","article-title":"Neutrophil extracellular traps and cancer-associated thrombosis","volume":"213","author":"Rosell","year":"2022","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1667\/RR3302","article-title":"Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses","volume":"163","author":"Gaugler","year":"2005","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jth.14364","article-title":"Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial","volume":"17","author":"Orsi","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2024.01.016_bb0230","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/eurheartj\/ehy014","article-title":"Rosuvastatin use improves measures of coagulation in patients with venous thrombosis","volume":"39","author":"Biedermann","year":"2018","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.thromres.2024.01.016_bb0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/jth.13640","article-title":"Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study","volume":"15","author":"Morelli","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.01.016_bb0240","first-page":"161","article-title":"Badimon perfusion chamber: an ex vivo model of thrombosis","volume":"2018","author":"Zafar","year":"1816","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.016_bb0245","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jth.14004","article-title":"Effect of rosuvastatin on risk markers for venous thromboembolism in cancer","volume":"16","author":"Ades","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"25","key":"10.1016\/j.thromres.2024.01.016_bb0250","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2016.71.3594","article-title":"Guideline-based statin eligibility, cancer events, and noncardiovascular mortality in the Framingham heart study","volume":"35","author":"Pursnani","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.016_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.726","article-title":"Real-world evidence for preventive effects of statins on cancer incidence: a trans-Atlantic analysis","volume":"12","author":"Gohlke","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"29","key":"10.1016\/j.thromres.2024.01.016_bb0260","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2016.71.8981","article-title":"Postdiagnosis statin use and mortality in Danish patients with prostate cancer","volume":"35","author":"Larsen","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.thromres.2024.01.016_bb0265","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1200\/JCO.2013.54.4569","article-title":"Statin use after colorectal cancer diagnosis and survival: a population-based cohort study","volume":"32","author":"Cardwell","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2024.01.016_bb0270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JCO.2009.23.4245","article-title":"Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era","volume":"28","author":"Nowakowski","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7326\/M18-2753","article-title":"Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a Nationwide Swedish population","volume":"171","author":"Simon","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","article-title":"Examining bias in studies of statin treatment and survival in patients with cancer","volume":"4","author":"Emilsson","year":"2018","journal-title":"JAMA Oncol."},{"issue":"32","key":"10.1016\/j.thromres.2024.01.016_bb0285","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1200\/JCO.2013.51.5593","article-title":"Common flaws in pharmacoepidemiologic study design and analysis","volume":"31","author":"Lund","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.thromres.2024.01.016_bb0290","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2016.69.7391","article-title":"Multicenter, phase III, randomized, double-blind, placebo-controlled trial of pravastatin added to first-line standard chemotherapy in small-cell lung cancer (LUNGSTAR)","volume":"35","author":"Seckl","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.thromres.2024.01.016_bb0295","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0300","first-page":"1629","article-title":"Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life","volume":"25","author":"Smith","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2024.01.016_bb0305","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1186\/s12885-018-4947-8","article-title":"Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink","volume":"18","author":"Chidwick","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.thromres.2024.01.016_bb0310","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:05Z","timestamp":1758736325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":62,"alternative-id":["S0049384824000161"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.01.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}